Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD
Published Online: Monday, September 16, 2013
Follow Pharmacy_Times:

This activity is supported by an educational grant from Acura Pharmaceuticals Inc.

Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD
Drug Information Specialist
Barnabas Health
South Plainfield, New Jersey



Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty
Shilpa Amara, PharmD

Pharmacy Times Office of Continuing Professional Education

Planning Staff
Judy V. Lum, MPA, and Steve Lin, PharmD

Pharmacy Times Editorial Staff
Kirk McKay and David Allikas

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.



Educational Objectives
 
Upon completion of the educational activity, the participant should be able to:
  1. Discuss the origins of methamphetamine abuse and its health and economic toll.
  2. Examine the current status of methamphetamine abuse following implementation of legal restrictions on purchasing of implicated OTC drugs.
  3. Identify further efforts taken to minimize use of OTC drugs for manufacture of methamphetamine.
  4. Identify pharmacy implications associated with use of OTC products in methamphetamine production.
Target audience:   Pharmacists
Type of activity:   Knowledge
Release date:   September 13, 2013
Expiration date:   September 13, 2015
Estimated time to complete activity:   2 hours
Fee:   Free

Click here to view this activity.

Related Articles
Maura Healey, Massachusetts’ new attorney general, plans to strengthen the state’s prescription monitoring program (PMP) as part of her larger goal of combating heroin use and prescription drug abuse.
Legislation to help curb prescription drug diversion and abuse and protect patients in need of medications received support from the National Association of Chain Drug Stores this week.
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the DEA has held pharmacists accountable for failing to verify controlled substance prescriptions for a legitimate medical purpose.
Methamphetamine users are about 3 times more likely to develop Parkinson’s disease than individuals who do not abuse the illegal drug.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$